PRM126 - A COMPARISON OF MIXTURE CURE AND STANDARD PARAMETRIC MODELING TO ESTIMATE LONG-TERM SURVIVAL FOR SMALL-CELL LUNG CANCER IN PATIENTS TREATED WITH NIVOLUMAB AFTER PROGRESSION

Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.2246
https://www.valueinhealthjournal.com/article/S1098-3015(18)35548-7/fulltext
Section Title :
Section Order : 1599
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35548-7&doi=10.1016/j.jval.2018.09.2246
HEOR Topics :
Tags :
Regions :